L. Palomera

531 total citations
21 papers, 216 citations indexed

About

L. Palomera is a scholar working on Hematology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, L. Palomera has authored 21 papers receiving a total of 216 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 7 papers in Molecular Biology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in L. Palomera's work include Lymphoma Diagnosis and Treatment (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). L. Palomera is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). L. Palomera collaborates with scholars based in Spain, South Korea and Mexico. L. Palomera's co-authors include Dong‐Gyu Jo, Guillermo Meléndez, Gemma Azaceta, Yoonsuk Cho, Han‐Gyu Bae, Junsik Kim, Jihoon Han, Hark Kyun Kim, Eunae Kim and Jae Hoon Sul and has published in prestigious journals such as Blood, Theranostics and Journal of Extracellular Vesicles.

In The Last Decade

L. Palomera

19 papers receiving 213 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Palomera Spain 9 114 46 37 37 31 21 216
Linlu Tian United States 11 149 1.3× 35 0.8× 31 0.8× 42 1.1× 45 1.5× 22 328
Huimin Chen China 11 129 1.1× 32 0.7× 36 1.0× 31 0.8× 7 0.2× 18 311
Haixin Dong China 9 60 0.5× 88 1.9× 26 0.7× 94 2.5× 17 0.5× 21 291
Laure Maneix United States 12 162 1.4× 63 1.4× 37 1.0× 40 1.1× 21 0.7× 24 353
Nupur Aggarwal United States 10 140 1.2× 28 0.6× 44 1.2× 42 1.1× 18 0.6× 15 342
Nina Martino United States 9 103 0.9× 22 0.5× 40 1.1× 45 1.2× 10 0.3× 15 315
A Scuto Italy 5 173 1.5× 19 0.4× 84 2.3× 22 0.6× 40 1.3× 6 301
Misagh Rajabinejad Iran 13 119 1.0× 36 0.8× 47 1.3× 38 1.0× 17 0.5× 21 391
Joel McCauley United States 10 264 2.3× 51 1.1× 35 0.9× 27 0.7× 8 0.3× 12 398
Preeti Kumari Chaudhary South Korea 7 126 1.1× 18 0.4× 39 1.1× 17 0.5× 31 1.0× 18 264

Countries citing papers authored by L. Palomera

Since Specialization
Citations

This map shows the geographic impact of L. Palomera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Palomera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Palomera more than expected).

Fields of papers citing papers by L. Palomera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Palomera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Palomera. The network helps show where L. Palomera may publish in the future.

Co-authorship network of co-authors of L. Palomera

This figure shows the co-authorship network connecting the top 25 collaborators of L. Palomera. A scholar is included among the top collaborators of L. Palomera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Palomera. L. Palomera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, Sun Young, Sang‐Ha Baik, L. Palomera, et al.. (2025). Hypoxia-mediated CRIP2 activation via NICD1 translocation regulates glycolysis and cell death. Genes & Diseases. 13(2). 101704–101704. 1 indexed citations
2.
Kim, Junsik, et al.. (2023). Dysregulation of histone deacetylases in ocular diseases. Archives of Pharmacal Research. 47(1). 20–39. 10 indexed citations
3.
Kim, Hark Kyun, Jun‐Hyung Cho, Eunae Kim, et al.. (2022). Engineered small extracellular vesicles displaying ACE2 variants on the surface protect against SARS‐CoV‐2 infection. Journal of Extracellular Vesicles. 11(1). e12179–e12179. 39 indexed citations
4.
Han, Jihoon, Hee-Jin Park, Chinmoyee Maharana, et al.. (2021). Alzheimer's disease-causing presenilin-1 mutations have deleterious effects on mitochondrial function. Theranostics. 11(18). 8855–8873. 47 indexed citations
5.
Palomera, L., Raúl Alcántara-Suárez, Lucía Angélica Méndez-García, et al.. (2019). A Single 48 mg Sucralose Sip Unbalances Monocyte Subpopulations and Stimulates Insulin Secretion in Healthy Young Adults. Journal of Immunology Research. 2019. 1–10. 8 indexed citations
6.
Palomera, L., et al.. (2018). Serum levels of interleukin-1 beta associate better with severity of simple steatosis than liver function tests in morbidly obese patients. Journal of Research in Medical Sciences. 23(1). 93–93. 11 indexed citations
7.
Palomera, L., et al.. (2018). Serum Levels of Interleukin-13 Increase in Subjects with Insulin Resistance but Do Not Correlate with Markers of Low-Grade Systemic Inflammation. Journal of Diabetes Research. 2018. 1–11. 29 indexed citations
8.
Salar, Antonio, Eva Domingo‐Doménech, Carlos Panizo, et al.. (2017). LONG‐TERM RESULTS OF THE MULTICENTER PHASE II TRIAL WITH BENDAMUSTINE AND RITUXIMAB AS FIRST LINE TREATMENT FOR PATIENTS WITH MALT LYMPHOMA (MALT‐2008‐01).. Hematological Oncology. 35(S2). 147–148. 2 indexed citations
9.
García‐Sánz, Ramón, Albert Oriol, María José Moreno, et al.. (2015). Zoledronic acid as compared with observation in multiple myeloma patients at biochemical relapse: results of the randomized AZABACHE Spanish trial. Haematologica. 100(9). 1207–1213. 24 indexed citations
10.
Ramírez-Labrada, Ariel, Patricia Galán‐Malo, Gemma Azaceta, et al.. (2014). Two death pathways induced by sorafenib in myeloma cells: Puma-mediated apoptosis and necroptosis. Clinical & Translational Oncology. 17(2). 121–132. 22 indexed citations
11.
Banzo, J., et al.. (2013). Evolution of solitary plasmacytoma of the sternum to multiple myeloma with multifocal extramedullary liver involvement. Contribution of 18F-FDG PET–CT. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 32(5). 328–329. 1 indexed citations
12.
13.
Canales, Miguel, Antonio Salar, José Luis Ferreiro, et al.. (2007). Safety of Intrathecal Liposomal Cytarabine (Depocyte®) Injection Given Prophylactically in Patients with High-Risk Diffuse Large B-Cell Lymphoma: A Report of 22 Patients in Spain.. Blood. 110(11). 4459–4459. 1 indexed citations
14.
García‐Marco, José A., L. Palomera, Alberto Fernández de Sevilla, et al.. (2006). Efficacy and Safety of DepoCyte® (Liposomal Cytarabine) in Patients with CNS Involvement from Non-Hodgkin’s Lymphoma (NHL): A Report on 32 Patients Treated in Spain.. Blood. 108(11). 2451–2451. 2 indexed citations
15.
Azaceta, Gemma, et al.. (1999). Successful lipid-complexed amphotericin B treatment of Candida arthritis in a lymphoma patient.. PubMed. 66(7-9). 434–5. 10 indexed citations
16.
Palomera, L., et al.. (1999). [Autoimmune thrombocytopenia in the clinical context of myelodysplasia with chromosome 7 deletion, intestinal tuberculosis, and chronic hepatitis caused by hepatitis C virus].. PubMed. 44(6). 495–6. 2 indexed citations
17.
Azaceta, Gemma, et al.. (1998). Primary orbital lymphoma: contralateral relapse after six years in complete remission.. PubMed. 83(3). 287–287. 1 indexed citations
18.
Palomera, L., et al.. (1998). Fatal myelofibrosis following fludarabine administration in a patient with indolent lymphoma.. PubMed. 83(11). 1045–6. 3 indexed citations
19.
Palomera, L., et al.. (1991). [Variant hairy-cell leukemia: immunophenotypic and ultrastructural study of a case].. PubMed. 36(2). 135–9. 1 indexed citations
20.
Palomera, L., et al.. (1982). [Acquired Von Willebrand's disease. A case report].. PubMed. 27(3). 397–406.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linlu Tian Breakdown of academic impact, for papers by Huimin Chen Breakdown of academic impact, for papers by Haixin Dong Breakdown of academic impact, for papers by Laure Maneix Breakdown of academic impact, for papers by Nupur Aggarwal Breakdown of academic impact, for papers by Nina Martino Breakdown of academic impact, for papers by A Scuto Breakdown of academic impact, for papers by Misagh Rajabinejad Breakdown of academic impact, for papers by Joel McCauley Breakdown of academic impact, for papers by Preeti Kumari Chaudhary
Rankless by CCL
2026